Over the last 7 days, the Life Sciences industry has dropped 1.6%, driven by a pullback from Agilent Technologies of 12%. Over the past 12 months, the industry was up 3.7%. As for the next few years, earnings are expected to grow by 17% per annum.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 05 Jun 2024 | US$706.0b | US$141.3b | US$12.4b | 38.5x | 56.8x | 5x |
Fri, 03 May 2024 | US$713.5b | US$141.7b | US$12.6b | 38.7x | 56.5x | 5x |
Sun, 31 Mar 2024 | US$744.3b | US$142.1b | US$12.8b | 44x | 58.2x | 5.2x |
Tue, 27 Feb 2024 | US$728.3b | US$142.1b | US$12.4b | 43.9x | 58.7x | 5.1x |
Thu, 25 Jan 2024 | US$695.8b | US$153.8b | US$14.2b | 35x | 49.1x | 4.5x |
Sat, 23 Dec 2023 | US$698.9b | US$153.8b | US$14.2b | 37.5x | 49.1x | 4.5x |
Mon, 20 Nov 2023 | US$610.6b | US$153.9b | US$13.9b | 33.5x | 43.9x | 4x |
Wed, 18 Oct 2023 | US$635.5b | US$154.6b | US$11.2b | 33.2x | 56.7x | 4.1x |
Fri, 15 Sep 2023 | US$692.7b | US$154.6b | US$11.2b | 33.3x | 61.8x | 4.5x |
Sun, 13 Aug 2023 | US$725.3b | US$154.7b | US$11.5b | 32x | 63.1x | 4.7x |
Tue, 11 Jul 2023 | US$692.1b | US$152.4b | US$12.5b | 29.6x | 55.3x | 4.5x |
Thu, 08 Jun 2023 | US$682.6b | US$152.4b | US$12.5b | 29.2x | 54.6x | 4.5x |
Sat, 06 May 2023 | US$702.8b | US$152.4b | US$12.9b | 30.5x | 54.6x | 4.6x |
Mon, 03 Apr 2023 | US$728.9b | US$154.6b | US$10.8b | 27x | 67.5x | 4.7x |
Wed, 01 Mar 2023 | US$711.7b | US$154.4b | US$10.8b | 28x | 65.7x | 4.6x |
Fri, 27 Jan 2023 | US$762.0b | US$155.5b | US$9.0b | 31.4x | 84.8x | 4.9x |
Sun, 25 Dec 2022 | US$743.5b | US$155.2b | US$8.8b | 28.8x | 84.7x | 4.8x |
Tue, 22 Nov 2022 | US$750.6b | US$154.9b | US$8.8b | 27.8x | 84.9x | 4.8x |
Thu, 20 Oct 2022 | US$703.1b | US$152.5b | US$17.0b | 25.1x | 41.3x | 4.6x |
Sat, 17 Sep 2022 | US$752.1b | US$152.3b | US$17.3b | 28.6x | 43.4x | 4.9x |
Mon, 15 Aug 2022 | US$845.8b | US$152.1b | US$17.3b | 32.6x | 49x | 5.6x |
Wed, 13 Jul 2022 | US$716.8b | US$148.0b | US$20.1b | 29.8x | 35.7x | 4.8x |
Fri, 10 Jun 2022 | US$736.9b | US$148.1b | US$20.1b | 30.2x | 36.7x | 5x |
Sun, 08 May 2022 | US$736.5b | US$147.7b | US$20.0b | 31.2x | 36.8x | 5x |
Tue, 05 Apr 2022 | US$880.6b | US$146.5b | US$25.3b | 36.5x | 34.8x | 6x |
Thu, 03 Mar 2022 | US$848.2b | US$146.2b | US$25.3b | 37.7x | 33.5x | 5.8x |
Sat, 29 Jan 2022 | US$829.5b | US$139.4b | US$27.9b | 38.8x | 29.8x | 6x |
Mon, 27 Dec 2021 | US$981.9b | US$138.0b | US$27.3b | 44.6x | 35.9x | 7.1x |
Wed, 24 Nov 2021 | US$953.8b | US$138.0b | US$27.3b | 41.8x | 34.9x | 6.9x |
Fri, 22 Oct 2021 | US$740.4b | US$106.0b | US$18.5b | 47.8x | 39.9x | 7x |
Sun, 19 Sep 2021 | US$757.4b | US$105.9b | US$18.6b | 51.6x | 40.6x | 7.2x |
Tue, 17 Aug 2021 | US$721.9b | US$105.8b | US$18.7b | 49.7x | 38.7x | 6.8x |
37.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.65% | |
Healthcare | 1.40% | |
Life Sciences | -1.59% | |
Clinical Research and Equipment | -1.59% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
DHR Danaher | US$267.85 | 4.7% +US$8.8b | 12.8% | PE48.8x | |
TMO Thermo Fisher Scientific | US$575.28 | 1.4% +US$3.0b | 10.5% | PE36.4x | |
ICLR ICON | US$329.65 | 6.5% +US$1.7b | 45.7% | PE39.9x | |
ILMN Illumina | US$106.79 | 4.9% +US$801.1m | -47.2% | PS3.8x | |
MEDP Medpace Holdings | US$407.77 | 5.1% +US$611.5m | 83.5% | PE40.4x |